Advances and ongoing controversies in PFO closure and cryptogenic stroke

Area of Science:

• Cardiology
• Neurology
• Vascular Medicine

Background:

• Cryptogenic stroke (CS) accounts for about one-third of all strokes.
• Patent foramen ovale (PFO) is more prevalent in CS patients than in those with known stroke origins.
• Paradoxical embolism across a PFO is a proposed mechanism for some CS.

Purpose of the Study:

• To review the evidence for patent foramen ovale (PFO) closure in preventing recurrent cryptogenic strokes (CS).
• To discuss patient selection criteria for PFO closure intervention.

Main Methods:

• Review of existing randomized clinical trials and scientific literature.
• Analysis of data comparing medical treatment versus transcatheter PFO closure for CS prevention.
• Evaluation of patient characteristics influencing treatment outcomes.

Main Results:

• Transcatheter PFO closure demonstrated superiority over medical treatment in preventing recurrent stroke in young CS patients.
• Evidence for PFO closure superiority in unselected CS populations is not yet established.
• Patient selection is crucial for optimizing outcomes of PFO closure.

Conclusions:

• Transcatheter PFO closure is a viable option for select patients with cryptogenic stroke, particularly younger individuals.
• Further research is needed to define optimal patient selection for PFO closure in broader populations.
• Understanding the role of PFO in CS is critical for guiding therapeutic strategies.